
The psychological and economic impact of endometriosis
The psychological and economic impact of endometriosis
We’re thrilled to present the third episode of Scailyte’s Endometriosis Awareness Series, where Cinzia Donato interviews Dr. Alina Staikov on “The psychological and economic impact of endometriosis”.
Dr. Staikov is a specialized gynecologist with a wealth of experience in the field. She completed her medical studies at the University of Sofia and specialized in gynecology and obstetrics at the Ruppiner Kliniken, an educational hospital of Charité in Berlin. Her passion for women’s health led her to establish gynecological and obstetrical consulting at the Center for Integrative Medicine in Zurich and work as a senior specialist at Seespital Horgen. Dr. Staikov is also certified in educational programs in gynecology and obstetrics.
In 2019, Dr. Staikov founded Gynpoint, a gynecology and obstetrics practice with locations in Zurich and Horgen, where she offers the whole spectrum of modern diagnostics and therapeutics. With over 7000 patients consulted each year, she has gained invaluable insights into the challenges faced by women with endometriosis.
Dr. Staikov plays an essential role in raising awareness of endometriosis as a collaborator with the Endometriosevereinigung-Schweiz. Her dedication to educating and supporting patients is commendable, and we’re honored to have her share her expertise in our interview.
Join us as we delve into endometriosis awareness among different age groups, the benefits of early diagnosis and the psychological and economic impact of endometriosis with Dr. Alina Staikov. Gain valuable insights into this complex condition and its far-reaching effects on women’s lives.
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
Recent News
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Recent News
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Recent News
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Recent News
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...
Recent News
ISCT 2023
Diana Stoycheva and Filipa Teixeira will be attending the ISCT 2023 Annual Meeting from 31st May to ...
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...